OPEN MONOCLONAL TECHNOLOGY, INC.;WUXI BIOLOGICS (CAYMAN) INC.
发明人:
ZHENG, YONG,LI, JING,CHEN, ZHISHENG
申请号：
CA2993276
公开号：
CA2993276A1
申请日:
2016.08.11
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.
